Scenarios identified to depict how EPBD IV may affect RE market value.(Residual Value = RV)
| Scenarios | ER interventions | Regulation framework | MV of NCPs |
|---|---|---|---|
| S0 | No (Ecn) | Current | 100% |
| SA.1 | No (Ecn) | EPBD IV @ 2040 | 0% |
| SA.2 | No (Ecn) | EPBD IV @ 2040 | Max (0,RV) |
| SB | Yes (up to ECn+2) | EPBD IV @ 2040 | 100% |
| SC | Yes (up to EC10) | EPBD IV @ 2050 | 100% |
| Scenarios | ER interventions | Regulation framework | MV of NCPs |
|---|---|---|---|
| S0 | No (Ecn) | Current | 100% |
| SA.1 | No (Ecn) | EPBD IV @ 2040 | 0% |
| SA.2 | No (Ecn) | EPBD IV @ 2040 | Max (0,RV) |
| SB | Yes (up to ECn+2) | EPBD IV @ 2040 | 100% |
| SC | Yes (up to EC10) | EPBD IV @ 2050 | 100% |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.